ALTSHULER DAVID
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to ALTSHULER DAVID. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| VRTX | EVP, Chief Scientific Officer | Sale | 52 | $424.69 | $22,084 | May 15, 2025 |
| VRTX | EVP, Chief Scientific Officer | Sale | 3,231 | $510.00 | $1,647,810 | Mar 13, 2025 |
| VRTX | EVP, Chief Scientific Officer | Sale | 3,231 | $500.00 | $1,615,500 | Mar 10, 2025 |
| VRTX | EVP, Chief Scientific Officer | Sale | 3,231 | $490.00 | $1,583,190 | Mar 3, 2025 |
| VRTX | EVP, Chief Scientific Officer | Sale | 1,272 | $480.00 | $610,560 | Feb 26, 2025 |
| VRTX | EVP, Chief Scientific Officer | Sale | 848 | $480.95 | $407,846 | Feb 24, 2025 |
| VRTX | EVP, Chief Scientific Officer | Sale | 1,111 | $480.00 | $533,280 | Feb 20, 2025 |
| VRTX | EVP, Chief Scientific Officer | Tax Withholding | 2,293 | $463.46 | $1,062,714 | Feb 14, 2025 |
| VRTX | EVP, Chief Scientific Officer | Award / Grant | 5,324 | — | — | Feb 12, 2025 |
| VRTX | EVP, Chief Scientific Officer | Tax Withholding | 2,142 | $467.98 | $1,002,413 | Feb 10, 2025 |
| VRTX | EVP, Chief Scientific Officer | Award / Grant | 7,114 | — | — | Feb 4, 2025 |
| VRTX | EVP, Chief Scientific Officer | Sale | 15 | $478.56 | $7,178 | Nov 15, 2024 |
| VRTX | EVP, Chief Scientific Officer | Sale | 54 | $430.93 | $23,270 | May 15, 2024 |
| VRTX | EVP, Global Research and CSO | Tax Withholding | 3,970 | $431.79 | $1,714,206 | Feb 26, 2024 |
| VRTX | EVP, Global Research and CSO | Sale | 3,002 | $421.77 | $1,266,154 | Feb 21, 2024 |
| VRTX | EVP, Global Research and CSO | Sale | 4,002 | $420.79 | $1,684,002 | Feb 20, 2024 |
| VRTX | EVP, Global Research and CSO | Tax Withholding | 2,099 | $422.74 | $887,331 | Feb 12, 2024 |
| VRTX | EVP, Global Research and CSO | Award / Grant | 7,114 | — | — | Feb 6, 2024 |
| VRTX | EVP, Global Research and CSO | Sale | 19 | $369.92 | $7,028 | Nov 15, 2023 |
| VRTX | EVP, Global Research and CSO | Sale | 63 | $345.51 | $21,767 | Aug 9, 2023 |
| VRTX | EVP, Global Research and CSO | Sale | 302 | $289.60 | $87,459 | Feb 24, 2023 |
| VRTX | EVP, Global Research and CSO | Sale | 900 | $294.73 | $265,257 | Feb 21, 2023 |
| VRTX | EVP, Global Research and CSO | Sale | 2,165 | $299.08 | $647,508 | Feb 14, 2023 |
| VRTX | EVP, Global Research and CSO | Sale | 1,893 | $299.36 | $566,688 | Feb 13, 2023 |
| VRTX | EVP, Global Research and CSO | Sale | 12 | $300.39 | $3,605 | Feb 6, 2023 |
| VRTX | EVP, Global Research and CSO | Award / Grant | 12,388 | — | — | Feb 1, 2023 |
| VRTX | EVP, Global Research and CSO | Sale | 34 | $308.61 | $10,493 | Nov 15, 2022 |
| VRTX | EVP, Global Research and CSO | Sale | 140 | $305.39 | $42,755 | Nov 7, 2022 |
| VRTX | EVP, Global Research and CSO | Sale | 210 | $293.02 | $61,534 | Aug 8, 2022 |
| VRTX | EVP, Global Research and CSO | Option Exercise | 7,338 | $155.57 | $1,141,573 | Jul 19, 2022 |
| VRTX | EVP, Global Research and CSO | Sale | 1,040 | $229.41 | $238,586 | Feb 24, 2022 |
| VRTX | EVP, Global Research and CSO | Sale | 986 | $229.22 | $226,011 | Feb 17, 2022 |
| VRTX | EVP, Global Research and CSO | Sale | 2,444 | $232.02 | $567,057 | Feb 14, 2022 |
| VRTX | EVP, Global Research and CSO | Sale | 98 | $237.23 | $23,249 | Feb 10, 2022 |
| VRTX | EVP, Global Research and CSO | Sale | 754 | $249.97 | $188,477 | Feb 2, 2022 |
| VRTX | EVP, Global Research and CSO | Sale | 14 | $186.80 | $2,615 | Nov 15, 2021 |
| VRTX | EVP, Global Research and CSO | Sale | 56 | $216.31 | $12,113 | May 17, 2021 |
| VRTX | EVP, Global Research and CSO | Sale | 646 | $211.58 | $136,681 | Feb 24, 2021 |
| VRTX | EVP, Global Research and CSO | Tax Withholding | 6,240 | $211.75 | $1,321,320 | Feb 18, 2021 |
| VRTX | EVP, Global Research and CSO | Sale | 500 | $211.67 | $105,835 | Feb 11, 2021 |
| VRTX | EVP, Global Research and CSO | Tax Withholding | 2,974 | $214.16 | $636,912 | Feb 10, 2021 |
| VRTX | EVP, Global Research and CSO | Award / Grant | 11,627 | — | — | Feb 3, 2021 |
| VRTX | EVP, Global Research and CSO | Sale | 18 | $223.57 | $4,024 | Nov 16, 2020 |
| VRTX | EVP, Global Research and CSO | Sale | 490 | $270.12 | $132,359 | Aug 6, 2020 |
| VRTX | EVP, Global Research and CSO | Sale | 100 | $279.98 | $27,998 | Aug 3, 2020 |
| VRTX | EVP, Global Research and CSO | Sale | 15 | $287.19 | $4,308 | May 15, 2020 |
| VRTX | EVP, Global Research and CSO | Sale | 1,304 | $287.33 | $374,678 | May 12, 2020 |
| VRTX | EVP, Global Research and CSO | Sale | 280 | $274.35 | $76,818 | May 6, 2020 |
| VRTX | EVP, Global Research and CSO | Sale | 500 | $262.45 | $131,225 | May 4, 2020 |
| VRTX | EVP, Global Research and CSO | Tax Withholding | 2,416 | $239.23 | $577,980 | Feb 25, 2020 |